3 news items
Mitsubishi Tanabe Pharma America Celebrates Eight-Year Anniversary in the U.S.
SYNH
29 Apr 24
". MTPC sets the MISSION of "Creating hope for all facing illness". To that end, MTPC is working on the disease areas of central nervous
Mitsubishi Tanabe Pharma America to Showcase Breadth of Neurodegenerative Research at 2024 American Academy of Neurology Annual Meeting
SYNH
12 Apr 24
the MISSION of "Creating hope for all facing illness." To that end, MTPC is working on the disease areas of central
Mitsubishi Tanabe Pharma America Receives U.S. Food and Drug Administration Orphan Drug Exclusivity for RADICAVA ORSĀ® (edaravone)
SYNH
8 Apr 24
has positioned health care as its strategic focus in its management policy, "Forging the future". MTPC sets the MISSION of "Creating hope
- Prev
- 1
- Next